ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,686Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 917

$647K Total Retail Price of All Prescriptions

Rank: 57 out of 917

399 Patients Receiving at Least One Drug in Part D
44%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 4,953 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 531 214 1 1
AMLODIPINE BESYLATE 432 228 2 5
METFORMIN HCL 430 187 3 8
LEVOTHYROXINE SODIUM 361 157 4 3
TRAMADOL HCL 349 99 5 28
SIMVASTATIN 330 176 6 2
OMEPRAZOLE 305 147 7 4
HYDROCHLOROTHIAZIDE 272 138 8 9
ATENOLOL 222 137 9 12
METOPROLOL TARTRATE 220 116 10 11
GLIPIZIDE 217 137 11 40
LOVASTATIN 215 106 12 19
FENOFIBRATE 213 67 13 73
TRAZODONE HCL 209 106 14 22
GABAPENTIN 205 73 15 17
CRESTOR 203 77 16 30
RANITIDINE HCL 187 102 17 29
ATORVASTATIN CALCIUM 169 75 18 14
FUROSEMIDE 161 77 19 7
CYCLOBENZAPRINE HCL 158 41 R 20 65
PROAIR HFA 155 53 21 35
WARFARIN SODIUM 144 64 22 10
CITALOPRAM HBR 134 78 23 15
ZOLPIDEM TARTRATE 134 43 23 21
ALENDRONATE SODIUM 129 111 25 23
NIASPAN 128 20 26 157
LANTUS 127 34 27 37
LOSARTAN POTASSIUM 125 95 28 13
METOPROLOL SUCCINATE 125 64 28 18
FLUOXETINE HCL 116 30 30 38
BUSPIRONE HCL 111 29 31 160
BACLOFEN 106 12 32 82
VENLAFAXINE HCL ER 106 37 32 78
POTASSIUM CHLORIDE 102 64 34 16
ENALAPRIL MALEATE 101 37 35 79
SPIRIVA 97 39 36 45
AMITRIPTYLINE HCL 93 20 R 37 67
ADVAIR DISKUS 90 51 38 47
IBUPROFEN 90 23 38 97
ALLOPURINOL 90 50 38 31
PAROXETINE HCL 84 35 41 57
COMBIVENT 82 43 42 148
PROPRANOLOL HCL 80 0 43 126
FLUTICASONE PROPIONATE 80 40 43 26
MIRTAZAPINE 79 22 45 39
VENTOLIN HFA 77 28 46 135
SERTRALINE HCL 76 32 47 24
INSULIN SYRINGE 72 26 48 83
OXYBUTYNIN CHLORIDE 69 33 49 76
HYDROCODONE-ACETAMINOPHEN 69 17 S3 49 6
CLONIDINE HCL 67 21 51 85
GEMFIBROZIL 66 21 52 140
PEN NEEDLE 59 20 53 99
QVAR 58 28 54 167
CARVEDILOL 58 13 54 33
RISPERIDONE 56 28 56 51
POLYETHYLENE GLYCOL 3350 55 33 57 66
CLOPIDOGREL 55 20 57 50
LEVEMIR FLEXPEN 53 21 59 197
LIPITOR 52 17 60 89
DIOVAN 51 28 61 49
LANTUS SOLOSTAR 50 27 62 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.